Skip to content
Friends of Cancer Research
About
About Friends
Team
Board of Directors
Financials & Policies
Projects
View All Projects
Research Partnerships
ctMoniTR Project
HRD Harmonization Project
TMB Harmonization Project
Real-World Evidence Portfolio
Policy & Regulatory Initiatives
Cell & Gene Therapies
Clinical Trial Eligibility Criteria
COVID-19
Lung-MAP
Tolerability in Cancer Clinical Trials
Analyses
Data Driven Insights
About Breakthrough Therapies
Search Breakthrough Therapies
Patient Resources
Education
Prevention, Detection, & Diagnosis
Clinical Trials
Find a Cancer Center
Glossary of Terms
Events
Upcoming Events
Past Events
Annual Meeting
News
In The News
Blog: Engaging Innovation
Press Releases
Publications
Donate
Search
Navigation Toggle
About
About Friends
Team
Board of Directors
Financials & Policies
Projects
View All Projects
Research Partnerships
ctMoniTR Project
HRD Harmonization Project
TMB Harmonization Project
Real-World Evidence Portfolio
Policy & Regulatory Initiatives
Cell & Gene Therapies
Clinical Trial Eligibility Criteria
COVID-19
Lung-MAP
Tolerability in Cancer Clinical Trials
Analyses
Data Driven Insights
About Breakthrough Therapies
Search Breakthrough Therapies
Patient Resources
Education
Prevention, Detection, & Diagnosis
Clinical Trials
Find a Cancer Center
Glossary of Terms
Events
Upcoming Events
Past Events
Annual Meeting
News
In The News
Blog: Engaging Innovation
Press Releases
Publications
Donate
twitter
linkedin
youtube
Keyword search
Submit
Search
Close
Beyond Breakthrough: Optimizing the Breakthrough Therapy Designation
Beyond Breakthrough: Optimizing the Breakthrough Therapy Designation
